1. Home
  2. BDSX

BDSX

Biodesix Inc.

Logo Biodesix Inc.

Health Care

Precision Instruments

Nasdaq

as 04-23-2024 12:31pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Founded: N/A Country:
United States
United States
Employees: N/A City: BOULDER
Market Cap: 138.3M IPO Year: 2020
Target Price: $3.50 AVG Volume (30 days): 164.3K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.64 EPS Growth: N/A
52 Week Low/High: $1.03 - $2.21 Next Earning Date: 05-09-2024
Revenue: $49,087,000 Revenue Growth: 28.46%
Revenue Growth (this year): 35.59% Revenue Growth (next year): 21.13%

Share on Social Networks:

Stock Insider Trading Activity of Biodesix Inc. (BDSX)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Vazquez Chris BDSX Chief Accounting Officer Feb 8 '24 Sell $1.92 1,077 $2,064.18 10,470 SEC Form 4
Vazquez Chris BDSX Chief Accounting Officer Feb 8 '24 Sell $1.66 922 $1,534.85 9,548 SEC Form 4
Pestano Gary Anthony BDSX Chief Development Officer Feb 8 '24 Sell $1.92 5,862 $11,235.11 128,272 SEC Form 4
Pestano Gary Anthony BDSX Chief Development Officer Feb 8 '24 Sell $1.66 5,022 $8,360.12 123,250 SEC Form 4
O'Kane Kieran BDSX Chief Commercial Officer Feb 8 '24 Sell $1.92 6,319 $12,111.00 73,417 SEC Form 4
O'Kane Kieran BDSX Chief Commercial Officer Feb 8 '24 Sell $1.66 5,412 $9,009.36 68,005 SEC Form 4